Report Feature
The future of the E.coli testing market looks promising with opportunities in commercial or private labs, physicians’ offices, hospitals, public health labs, and academic research institutes. The global E.coli testing market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing awareness of hygiene, government regulations regarding water and food management, government funding for performing diagnostic tests, non-government organizations (NGOs) campaigns on water management, and increasing prevalence of diarrhea.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global E.Coli testing market report, please download the report brochure.
In this market, monoclonal antibodies is the largest technology segment of E.coli testing, whereas development of public health labs is the largest end user. Growth in various segments of the E.coli testing market are given below:
The study includes trends and forecast for the global E.Coli tetsing market by technology, end user, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Monoclonal Antibodies
- Differential Light Scattering
- Molecular Diagnostics
- Immunoassays
- Chromatography
- Flow Cytometry
- Gel Microdroplets
- Diagnostic Imaging
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Commercial or Private Labs
- Physicians’ Offices
- Hospitals
- Public Health Labs
- Academic Research Institutes
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the E.Coli testing companies profiled in this report include Bio-Rad Laboratories, Pro-Lab Diagnostics, Abbott, IDEXX Laboratories, Meridian Bioscience, BD, Thermo Fisher Scientific, CPI International, Biomerieux, and Hologic.
Lucintel forecasts that monoclonal antibodies will remain the largest segment over the forecast period owing to advantages of these antibodies over the polyclonal antibodies for determining the presence of E.coli in test samples. In addition, this type of antibodies ensures low cross-reactivity, high specificity, and excellent lot-to-lot stability during the E.coli testing.
Within this market, public health labs will remain the largest end use segment over the forecast period due to increasing prevalence of diarrhea and increasing awareness.
North America will remain the largest region over the forecast period due to increased government funding on healthcare infrastructure and technological advancement in E.coli diagnostic procedures in the region.
|
Features of the Global E.Coli Testing Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global E.Coli testing market by technology (monoclonal antibodies, differential light scattering, molecular diagnostics, immunoassays, chromatography, flow cytometry, gel microdroplets, and diagnostic imaging), end user (commercial or private labs, physicians’ offices, hospitals, public health labs, and academic research institutes), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global E.Coli testing market? Q.5 What are the business risks and threats to the global E.Coli testing market? Q.6 What are the emerging trends in this E.Coli testing market and the reasons behind them? Q.7 What are some changing demands of customers in this E.Coli testing market? Q.8 What are the new developments in this E.Coli testing market? Which companies are leading these developments? Q.9 Who are the major players in this E.Coli testing market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this E.Coli testing market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global E.Coli testing market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | By Technology (Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging), and End User (Commercial or Private Labs, Physicians’ Offices, Hospitals, Public Health Labs, and Academic Research Institutes) |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
4.1 Global E.Coli testing Market by Region
4.2.1 Market by Technology: Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging
4.2.2 Market by End User: Commercial or Private Labs, Physicians’ Offices, Hospitals, Public Health Labs, and Academic Research Institutes
4.2.3 The United States E.Coli testing Market
4.2.4 The Canadian E.Coli testing Market
4.2.5 The Mexican E.Coli testing Market
4.3.1 Market by Technology: Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging
4.3.2 Market by End User: Commercial or Private Labs, Physicians’ Offices, Hospitals, Public Health Labs, and Academic Research Institutes
4.3.3 The United Kingdom E.Coli testing Market
4.3.4 The Spanish E.Coli testing Market
4.3.5 The German E.Coli testing Market
4.3.6 The French E.Coli testing Market
4.4.1 Market by Technology: Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging
4.4.2 Market by End User: Commercial or Private Labs, Physicians’ Offices, Hospitals, Public Health Labs, and Academic Research Institutes
4.4.3 The Chinese E.Coli testing Market
4.4.4 The Indian E.Coli testing Market
4.4.5 The Japanese E.Coli testing Market
4.5.1 Market by Technology: Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging
4.5.2 Market by End User: Commercial or Private Labs, Physicians’ Offices, Hospitals, Public Health Labs, and Academic Research Institutes
4.5.3 Brazilian E.Coli testing Market
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
